Robert Hazlett's Stock Ratings

BTIG Analyst

Robert Hazlett is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/01/2025

Overall Average Return

-19.5%

Smart Score

37.3%

Overall Average Return Percentile

13th

Number of Ratings

47
Buy NowGet Alert
10/18/2024AURABuy Now
Aura Biosciences
$5.67323.28%
Robert Hazlett37%
$21 → $24MaintainsBuyGet Alert
09/30/2024NKTRBuy Now
Nektar Therapeutics
$0.66504.96%
Robert Hazlett37%
→ $4Assumes → BuyGet Alert
05/09/2024RANIBuy Now
Rani Therapeutics Hldgs
$1.271002.36%
Robert Hazlett37%
$7 → $14MaintainsBuyGet Alert
12/08/2023AURABuy Now
Aura Biosciences
$5.67270.37%
Robert Hazlett37%
$38 → $21MaintainsBuyGet Alert
08/03/2023ARAVBuy Now
Aravive
——
Robert Hazlett37%
—DowngradeBuy → NeutralGet Alert
05/15/2023SEELBuy Now
Seelos Therapeutics
$0.39925.64%
Robert Hazlett37%
$42240 → $15360MaintainsBuyGet Alert
03/30/2023SEELBuy Now
Seelos Therapeutics
$0.392720.51%
Robert Hazlett37%
→ $42240MaintainsBuyGet Alert
02/13/2023SEELBuy Now
Seelos Therapeutics
$0.392976.92%
Robert Hazlett37%
$46080 → $46080MaintainsBuyGet Alert
02/07/2023LYRABuy Now
Lyra Therapeutics
$0.1216566.67%
Robert Hazlett37%
$24 → $20MaintainsBuyGet Alert
12/23/2022AXSMBuy Now
Axsome Therapeutics
$110.89-11.62%
Robert Hazlett37%
$62 → $98MaintainsBuyGet Alert
10/05/2022VSTMBuy Now
Verastem
$5.90-15.25%
Robert Hazlett37%
$96 → $60MaintainsBuyGet Alert
09/07/2022EIGRBuy Now
Eiger BioPharmaceuticals
——
Robert Hazlett37%
$1710 → $1440MaintainsBuyGet Alert
08/16/2022FIXXBuy Now
Homology Medicines
——
Robert Hazlett37%
$522 → $216MaintainsBuyGet Alert
04/28/2022SEELBuy Now
Seelos Therapeutics
$0.392976.92%
Robert Hazlett37%
→ $46080MaintainsBuyGet Alert
03/15/2022NKTRBuy Now
Nektar Therapeutics
$0.66—
Robert Hazlett37%
—DowngradeBuy → NeutralGet Alert
02/23/2022ZSANBuy Now
Zosano Pharma
——
Robert Hazlett37%
—DowngradeBuy → NeutralGet Alert
02/22/2022FIXXBuy Now
Homology Medicines
——
Robert Hazlett37%
$630 → $522MaintainsBuyGet Alert
12/15/2021GRTXBuy Now
Galera Therapeutics
$0.0350362.57%
Robert Hazlett37%
→ $15UpgradeNeutral → BuyGet Alert
11/23/2021AURABuy Now
Aura Biosciences
$5.67570.19%
Robert Hazlett37%
→ $38Initiates → BuyGet Alert
10/19/2021GRTXBuy Now
Galera Therapeutics
$0.03—
Robert Hazlett37%
—DowngradeBuy → NeutralGet Alert
08/25/2021RANIBuy Now
Rani Therapeutics Hldgs
$1.271789.76%
Robert Hazlett37%
→ $24Initiates → BuyGet Alert
08/09/2021CTICBuy Now
CTI BioPharma
——
Robert Hazlett37%
→ $7Initiates → BuyGet Alert
05/27/2021CMPSBuy Now
Compass Pathways
$2.902072.41%
Robert Hazlett37%
→ $63Initiates → BuyGet Alert
05/24/2021VSTMBuy Now
Verastem
$5.9035.59%
Robert Hazlett37%
→ $96UpgradeNeutral → BuyGet Alert
04/16/2021TCONBuy Now
TRACON Pharma
$0.0343378.26%
Robert Hazlett37%
→ $280UpgradeNeutral → BuyGet Alert
03/12/2021SEELBuy Now
Seelos Therapeutics
$0.393489.74%
Robert Hazlett37%
→ $53760Initiates → BuyGet Alert
03/08/2021ARAVBuy Now
Aravive
——
Robert Hazlett37%
→ $26Initiates → BuyGet Alert
02/02/2021PRTABuy Now
Prothena Corp
$12.09139.87%
Robert Hazlett37%
→ $29UpgradeNeutral → BuyGet Alert
11/02/2020ITCIBuy Now
Intra-Cellular Therapies
$131.90-69.67%
Robert Hazlett37%
$80 → $40MaintainsBuyGet Alert
09/11/2020RDHLBuy Now
Redhill Biopharma
$2.55919.61%
Robert Hazlett37%
→ $26000Initiates → BuyGet Alert
09/04/2020AKBABuy Now
Akebia Therapeutics
$1.92212.5%
Robert Hazlett37%
$26 → $6MaintainsBuyGet Alert
03/27/2020ZSANBuy Now
Zosano Pharma
——
Robert Hazlett37%
$560 → $245MaintainsBuyGet Alert
03/03/2020ITCIBuy Now
Intra-Cellular Therapies
$131.90-48.45%
Robert Hazlett37%
$73 → $68MaintainsBuyGet Alert
12/02/2019GRTXBuy Now
Galera Therapeutics
$0.03100825.15%
Robert Hazlett37%
→ $30Initiates → BuyGet Alert
07/13/2018VSTMBuy Now
Verastem
$5.90188.14%
Robert Hazlett37%
→ $204Initiates → BuyGet Alert
06/28/2018ZSANBuy Now
Zosano Pharma
——
Robert Hazlett37%
→ $665Initiates → BuyGet Alert
04/24/2018FIXXBuy Now
Homology Medicines
——
Robert Hazlett37%
→ $630Initiates → BuyGet Alert
04/24/2018PRTABuy Now
Prothena Corp
$12.09—
Robert Hazlett37%
—DowngradeBuy → NeutralGet Alert
12/07/2017AKBABuy Now
Akebia Therapeutics
$1.921462.5%
Robert Hazlett37%
→ $30Initiates → BuyGet Alert
10/16/2017KALVBuy Now
KalVista Pharma
$11.15142.04%
Robert Hazlett37%
$18 → $27MaintainsBuyGet Alert
09/29/2017PRTABuy Now
Prothena Corp
$12.09536.89%
Robert Hazlett37%
$80 → $77MaintainsBuyGet Alert
08/31/2017KALVBuy Now
KalVista Pharma
$11.1561.36%
Robert Hazlett37%
→ $18Initiates → BuyGet Alert
08/31/2017CMTABuy Now
Clementia Pharmaceuticals Inc. - Common Shares
——
Robert Hazlett37%
→ $32Initiates → BuyGet Alert
05/19/2017PRTABuy Now
Prothena Corp
$12.09561.7%
Robert Hazlett37%
→ $80Initiates → BuyGet Alert
05/19/2017AXSMBuy Now
Axsome Therapeutics
$110.89-87.37%
Robert Hazlett37%
→ $14Initiates → BuyGet Alert
04/21/2017CASCBuy Now
Cascadian Therapeutics
——
Robert Hazlett37%
→ $13Initiates → BuyGet Alert
08/19/2016TCONBuy Now
TRACON Pharma
$0.0346483.85%
Robert Hazlett37%
→ $3000Initiates → BuyGet Alert